Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06561425
Title A Study Evaluating the Safety and Efficacy of GLPG5101 (19CP02) in Participants With Non-Hodgkin Lymphoma (Atalanta-1)
Acronym Atalanta-1
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Galapagos NV
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | BEL


No variant requirements are available.